This note investigates a number of scenarios in which unadjusted testing following a blinded sample size re-estimation leads to type I error violations. For superiority testing, this occurs in certain smallsample borderline cases. We discuss a number of alternative approaches that keep the type I error rate. The paper also gives a reason why the type I error inflation in the superiority context might have been missed in previous publications and investigates why it is more marked in case of non-inferiority testing.
Introduction
Sample Size re-estimation (SSR) in clinical trials has a long history that dates back to Stein (1945) . A sample size review at an interim analysis aims at correcting assumptions which were made at the planning stage of the trial, but turn out to be unrealistic. When the sample units are considered to be normally distributed, this typically concerns the initial assumption about the variation of responses. Wittes and Brittain (1990) and Shih (1992, 1998 ) among others discussed methods of blinded SSR. In contrast 1 Novartis Pharma AG, CH-4002 Basel, Switzerland 2 Otto-von-Guericke-Universität Magdeburg, 39114 Magdeburg, Germany to unblinded SSR, blinded SSR assumes that the actually realized effect size estimate is not disclosed to the decision makers who do the SSR. Wittes et al. (1999) and Zucker et al. (1999) investigated the performance of various blinded and unblinded SSR methods by simulation. They observed some slight type I error violations in cases with small sample size and gave explanations for this phenomenon for some of the unblinded approaches available at that time.
Slightly later, Kieser and Friede([1] , [2] ) suggested a method of blinded sample size review which is particularly easy to implement. In a trial with normally distributed sample units with the aim of testing for a significant treatment effect ("superiority testing") at the final analysis, it estimates the variance under the null hypothesis of no treatment effect and then proceeds to an unmodified t-test in the final analysis, i.e. a test that ignores the fact that the final sample size was not fixed from the onset of the trial. Kieser and Friede investigated the type I error control of their suggestion by simulation.
They conclude that no additional measures to control the significance level are required in these designs if the study is evaluated with the common t-test and the sample size is recalculated with any of these simple blind variance estimators.
Although Kieser and Friede explicitly stated that they provide no formal proof of type I error control, it seems to us that many statisticians in the pharmaceutical industry are under the impression that such a proof is available. This, however, is not the case. In this paper, we show that in certain situations, the method suggested by Kieser and Friede does not control the type I error.
It should be emphasized that asymptotic type I error control with blinded SSR is guaranteed. If the sample size of only one of the two stages tends to infinity, the other stage is obviously irrelevant for the asymptotic value of the final test statistic and thus the method asymptotically keeps α. If the sample size in both stages goes to infinity, then the stage-1-estimate of the variance converges to a constant value. Hence, whatever sample size reestimation rule is used, it implicitly fixes the total sample size in advance (though its precise value is not yet known before the interim). In any case, asymptotically α is again kept. Govindarajulu (2003) has formalized this thought and extended to non-normally distributed data. As a consequence, the type I error violations discussed in this note are very small and occur in cases with small samples. We still believe, however, that the statistical community should be made aware of these limitations of blinded sample-size review methodology.
While sections 2-4 focus on the common case of testing for treatment differences in clinical trials, section 5 briefly discusses the case of testing for non-inferiority of one of the two treatments. In had been noted in another paper by Friede and Kieser [13] that type I error inflations from SSR can be more marked in this situation. We give an explanation of this phenomenon.
A scenario leading to type I error violation
In this section we show that in certain cases, a blinded sample size review as suggested by [1] leads to a type I error which is larger than the nominal level α.
In general, blinded sample review is characterized by the fact that the final sample size of the study may be changed at interim analyses, but that this change depends on the data only via the total variance which is the variance estimate under the null hypothesis of interest. If x i , i = 1, . . . , n 1 are stochastically independent normally distributed observations, this total variance is proportional to
in the one-sample and to
in the two-sample case.
We consider the one-sample t test of H 0 : µ = 0 at level α applied to
2 ). The reason for this is simplicity of notation and the fact that the geometric considerations given below cannot be imagined for the twosample case which would have to deal with a dimension larger than three even in the simplest setup. However, the restriction to the one-sample case entails no loss of generality, as it is conceptually the same as the two sample case.
We will briefly comment on this further below. In addition, a blinded sample size review may also be of practical relevance in the one-sample situation, for example in cross-over trials.
Assume a blinded sample size review after n 1 = 2 observations. If the total variance is small, we stop sampling and test with the n 1 = n = 2 observations we have obtained. If it is large, we take another sample element x 3 , and do the test with n = 3 observations. This rule implies that n = 2 for x 2 1 + x 2 2 ≤ r 2 and n = 3 otherwise for some fixed scalar r. Geometrically, the rejection region of the (one-sided) t test for n = 3 is a spherical cone with the equiangular line x 1 = x 2 = x 3 as its central axis in the threedimensional space. By definition, the probability mass of this cone is α under H 0 . For the case of n = 2, the rejection region is a segment of the circle arbitrary. The probability mass covered by this segment again is α inside the cylinder. The rejection region of the entire procedure is the segment of the cylinder plus the spherical cone minus the intersection of the cone with the cylinder. We now approximate the probability mass of these components.
For r 2 small, we approximately have
Hence, under H 0 , the probability mass of this part of the rejection region is approximately r. The approximate volume of the intersection is
To conservatively approximate the probability mass of this intersection, we assume that every point in it has the same probability mass as the origin (in reality, it of course has a lower probability mass). Then the probability mass of the intersection is approximated by
is the value of the standard normal density N 3 (0, σ 2 I 3 ) in the point 0. Combining these results, a conservative approximation of the probability mass of the rejection region for the entire procedure is
Obviously, this is larger than α for small r.
For the more general case of a stage-1-sample size of n 1 , possibly followed by a stage 2 with n 2 further observations, the rejection region of the "sample size reviewed" t test has an approximate null probability following the same basic principle as (1):
if r, n 1 and n 2 are small.
Consequently, there must be situations with small
where the blinded review procedure cannot keep the type I error level α exactly. Due to symmetry of the rejection region, this statement holds for both the one-and the two-sided test of H 0 .
Note that in this example, the test keeps α exactly if
2 . This is due to the sphericity of the conditional null distribution of (
, theorem 2.5.8). Type I error violation stems from the fact that the test does not keep α conditional on
if a second stage of sampling more observations is done.
To investigate the magnitude of the ensuing type I error violation, we simulated 10'000'000 cases with n 1 = 2 initial observations and n 2 = 2 additional observations that are only taken if x If n 1 and n 2 are increased, the true type I error rate converges rather quickly to α. For example, in case of n 1 = n 2 = 5 and r 2 = 2.5, the simulated error rate is 0.0508 with 77.6% of cases leading to stage 2 and a conditional error rate of 0.0510 in case stage 2 applies.
We also performed some simulations where n 2 is determined with the algorithm suggested by [1] . For this purpose, we generated 10 ′ 000 ′ 000 simulation runs of a blinded sample size review after n 1 = 2 observations following the rule given in section 3 of [1] with a very large assumed effect of δ = 2.2.
This produces an average of 3.09 additional observations n 2 . The simulated type I error was 0.05077.
To see that the two-sample case is also covered by these investigations, note that the ordinary t-test statistic can be viewed as X/ Y /s where ing the additional sample size n 2 from the first n 1 observations, we apply the permutation method to all n 1 + n 2 observations. The special case of n 2 = 0 is possible and then the parametric (non-permutation) t-test can also be used.
This strategy keeps the α-level exactly, because the total variance
is invariant to the permutations.
In the two-sample case, the approach would permute the treatment allocations of the observations. In order to preserve the observed total variance, the permutations have to be done separately for the n 1 observations of stage 1 and the n 2 observations of stage 2, respectively.
If sample sizes are small, permutation tests suffer from the discreteness of the resampling distribution and the associated loss of power. In this case, rotation tests [4, 5] offer an attractive alternative. These replace the random permutations of the sample units by random rotations. This renders the sup-port of the corresponding empirical distribution continuous and thus avoids the discreteness problem of the permutation strategy. In order to facilitate this, rotation tests require the assumption of a spherical null distribution. This is the case in this context. Stage-1-and stage-2-data have to be rotated separately even in the one-sample case in order to keep the fixed observed stage-1-value of the total variance.
Permutation and rotation strategies emulate the true distribution of the t test including sample size review. Hence, they will "automatically" correct any type I error inflation as outlined in the previous section, but will otherwise have almost identical properties (e.g. with respect to power) as their "parametric" counterpart. We did some simulations of the permutation and rotation strategies under null and non-null scenarios. These, however, just backed up the statements made here and are thus not reported.
Combinations of test statistics from the two stages
Methods that use a combination of test statistics from the two stages are another alternative if one is looking for an exact test. For example, we might use Fisher's p-value combination −2 log(p 1 · p 2 ) [6] where p j = P (T j > t j ) with T j being the test statistic from stage-j-data only and t j its observation from the concrete data at hand. As −2 log(p 1 · p 2 ) ∼ χ 2 (4) for independent test statistics T 1 and T 2 under H 0 , the combination p-value test rejects H 0 if −2 log(p 1 · p 2 ) is larger than the (1 − α)-quantile from this distribution. In this application, we use the true null distributions of the test statistics T j to determine the p-values. For example, in case of the one-sample-t-test these are the t-distributions T 1 ∼ t(n 1 − 1) and T 2 ∼ t(n 2 − 1).
The stage-2-sample size n 2 is uniquely determined by
Since T 1 is a test statistic for which Theorem 2.5.8. of [3] holds under H 0 , the null distribution of T 1 is valid also conditionally on
. As a consequence, T 1 ∼ t(n 1 − 1) and T 2 ∼ t(n 2 − 1) are stochastically independent under H 0 for given (and hence a z-test for H 0 could be done), then the optimal (standardized) weights for combining the z-statistics from the two stages would be n 1 n 1 +n 2 and n 2 n 1 +n 2 in the one-sample case. Hence, t comb = n 1 n 1 +n 2 t 1 + n 2 n 1 +n 2 t 2 seems a promising candidate for a combination test statistic. The fact that {T j } , j = 1, 2 retain their t(n j − 1)-null distributions if we condition on
i means that critical values for this test can be obtained from the distribution of the weighted sum of two stochastically independent tdistributed random variables with (n 1 − 1) and (n 2 − 1) degrees of freedom, respectively. It is obvious that this is very easy with numerical integration or a simulation. Comparing t comb with these critical values (that depend only on n 1 and n 2 ) to decide about the rejection of H 0 gives an exact level-α test.
To investigate the performance of the introduced suggestions, we did sev-eral simulations. The critical values for the one-sided one-sample test using t comb were obtained by simulating 1'000'000 values of two independent tdistributions with n 1 fixed and n 2 as determined by the SSR method in [1] .
We used the "total variance" for SSR, not the "adjusted variance" which subtracts a constant based on the putative effect size. Nevertheless, the reestimated sample size of course depends on the "assumed effect" which may be different from the true, unknown effect size. In the simulations,we investigated various combinations of the true effect size µ and an assumed effect size δ. effect size, such that the non-centrality parameter of a standard-t-test with n observations would be √ nµ) and varying values of δ on the x-axis. The unmodified t-test as suggested by [1] is always best. In comparison, the weighted t-test combination t comb suffers from a small power loss which seems non-negligible only for very small stage-1-sample sizes below n 1 = 10 (where the type I error control of the "reviewed" t-test might be a concern). For all simulated scenarios with n 1 = 30, the difference in power was always below 1%. In contrast, Fisher's p-value combination typically loses 3 to 4 % of power when t-test power is less than 95 % and up to 7% for some scenarios (µ = 0.1, δ = 0.15 with power t-test 76.4%, power t-combination 76.3%, power p-value combination 69.6%).
The distribution of Kieser and Friede's ttest statistic
To investigate the type I error of the t-test after a blinded sample size review, Kieser and Friede [1] write the t-test statistic as a function of four components
2 (see page 3575 of [1] ) for which they derive respective distributions. However, the distribution of V * 2 given (D 1 , V 1 ) mentioned there is an approximation, not the exact distribution. Hence, the "actual" type I error rates in [1] are also approximate, possibly masking a minor type I error level inflation.
The following uses the notation from [1] . It shows that the conditional
Without loss of generality it can be assumed that σ 2 = 1. We have
is obvious. It is also obvious that if we condition on V 1 only, and suppose that this determines sample size n 2 uniquely, we have
such that D * 1 and D * 2 are stochastically independent. Thus, in this case
holds. This was noted by [7] . shown that the true conditional distribution of V * 2 is a mixture distribution:
where "= d " denotes "equal in distribution" and z 2 2 has the "rescaled" noncentral
2 ) will often very closely approximate this real distribution.
5 Sample size reviews when testing for noninferiority
The preceding sections have dealt with the superiority test H 0 : µ = 0.
While type I error violations in this context are extremely small, it was noted by [13] that more serious violations arise in the case of non-inferiority and equivalence testing and that these are persistent with larger sample sizes.
This section gives an intuitive explanation for this.
Assume that in the two-sample case, it is intended to test the non-
2 ) where i = 1, 2 indexes stage, j = 1, 2 treatment group, k = 1, . . . , n i sample unit and δ is a fixed non-inferiority margin. Sample size reassessment after stage 1 determines the stage-2-sample size via
(where u α is the α-quantile of N(0, 1), β is the desired power of the ordinary two-sample t-test and θ is the assumed true effect difference between the treatments) as a function of the "total variance"
. This, however, does not correspond to a "blinded" sample size review of the corresponding superiority test. To see this, notice that the described test can also be represented as a test of H 0 : µ * 1 − µ 2 ≤ 0 on the "shifted" data
A blinded sample size review of x * ijk would also use (2), but witĥ
It is easy to see that
This formula contains the quantity
δ(x 11 −x 12 ) which links the realized difference in meansx 11 −x 12 with the true difference δ of means under H 0 . If, for example, δ < 0, then n 2 decreases with increasing realized values ofx 11 − x 12 . Relative to the blinded superiority sample size review, this means that fewer additional sample elements are taken when stage-1-evidence is in favor of the alternative and vice versa. Obviously, this must be associated with an increase of type I error under H 0 . Conversely, the test gets conservative when δ > 0. These tendencies were also noticed by [13] in simulations.
The "blinded" non-inferiority test is thus equivalent to an "unblinded" superiority test and hence subject to type I error biases that afflict an unmodified t-test applied after the sample size was modified using the observed difference in means. To be sure, the user of the blinded non-inferiority reestimation does not get to see the realized value ofx 11 −x 12 , but nevertheless it has the described impact on the modified sample size n 2 .
Discussion
This paper investigates a number of situations with normally distributed observations where blinded sample size review according to Kieser and Friede does not control the type I error rate. In superiority testing, the corresponding inflations are extremely small and occur with sample sizes that will rarely be of practical relevance. The method can thus safely be used in practice.
As an alternative for which type I error control can be proved, it is also possible to combine the t-test statistics of the two stages directly using data-dependent weights. Regarding the outcome in practical applications, these two methods are virtually indistinguishable. In contrast, p-valuecombination and related methods suffer from some power loss due to the fact that they have to work with a predetermined "intended" stage-2-sample size and lose power if one deviates from this intention in the sample size review.
Non-inferiority testing is subject to much more severe type I error violations. This is due to its equivalence with unblinded superiority testing.
As a consequence, blinded SSR is not an acceptable method in confirmatory clinical trials.
